Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Alliance Pharma (APH)

Price 44.50p on 21-11-2024 at 17:30:00
Change 0.20p 0.45%
Buy 44.80p
Sell 44.35p
Buy / Sell APH Shares
Last Trade: Sell 2,085.00 at 44.50p
Day's Volume: 2,009,141
Last Close: 44.50p
Open: 44.40p
ISIN: GB0031030819
Day's Range 44.20p - 45.20p
52wk Range: 24.55p - 49.20p
Market Capitalisation: £241m
VWAP: 44.96094p
Shares in Issue: 541m

Recent Trades History Alliance Pharma (APH)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 2,085 44.50p Automatic Execution
16:35:11 - 21-Nov-24
Sell* 29,481 44.50p Uncrossing Trade
16:35:11 - 21-Nov-24
Sell* 5 44.35p Automatic Execution
16:29:56 - 21-Nov-24
Sell* 2,114 44.35p Automatic Execution
16:29:50 - 21-Nov-24
Buy* 2 44.65p Automatic Execution
16:28:34 - 21-Nov-24
Sell* 491 44.30p Automatic Execution
16:26:10 - 21-Nov-24
Sell* 1,959 44.30p Automatic Execution
16:26:10 - 21-Nov-24
Sell* 21 44.30p Automatic Execution
16:25:59 - 21-Nov-24
Sell* 4,209 44.30p Automatic Execution
16:20:09 - 21-Nov-24
Sell* 2,265 44.372p Ordinary
16:16:50 - 21-Nov-24

Share Price History for Alliance Pharma

Time period:
to
Date Open High Low Close Volume

Share News for Alliance Pharma

EARNINGS: Alliance Pharma swings to profit; DG Innovate loss widens

30th Sep 2024 18:37

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

UK earnings, trading statements calendar - next 7 days

23rd Sep 2024 14:12

Read More

EXECUTIVE CHANGES: New chief executives at Cornish Metals and ValiRx

12th Aug 2024 12:01

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced in August so far and not separately reported by Alliance News: Read More

IN BRIEF: Alliance Pharma trading in line, revenue edges higher

29th Jul 2024 16:20

Alliance Pharma PLC - Chippenham, Wiltshire-based distributor of consumer healthcare brands and prescription medicines - Issues trading update for the six months to June 30. Expects revenue of GBP84.8 million, up 2.8% from GBP82.4 million a year prior. Consumer Healthcare revenues rise 5% to GBP61.4 million, prescription medicine revenues grows 3.4% to GBP23.3 million. Continues to expect group revenue to build throughout the second half, driving gross margin improvement which will be used to support further investment in marketing and innovation. Continues to anticipate that full-year profitability will be in line with financial 2023. Expects net debt and leverage to fall further in the second half, reflecting the group's strong cash generation. Read More

IN BRIEF: Alliance Pharma nixes chief operating officer role

23rd Jul 2024 20:53

Alliance Pharma PLC - Chippenham, Wiltshire-based distributor of consumer healthcare brands and prescription medicines - Says Chief Operating Officer Jeyan Heper will leave the business on August 31. Heper joined the group in February last year, and has been helping to identify growth opportunities in international consumer healthcare markets. Alliance Pharma explains that in order to accelerate the globalisation of the business, and to simplify the company's management structure, the board has decided that the role of COO is no longer a requirement at Alliance. Read More

FTSE 100 Latest
Value8,149.27
Change64.20

Login to your account

Forgot Password?

Not Registered